The future is very promising both for Neuronano as a company and for patients who currently suffer from or are limited by disease, and who may be helped by the technology tomorrow. 

The brain controls most functions  in the body and with electrodes that both register signals and that can produce stimulation, the therapeutic possibilities are nearly endless. 

Neuronano is approaching the clinical phase for Parkinson’s patients.